Navigation Links
Meeting to examine FDA requirements for manufacturing PET radiopharmaceuticals
Date:3/26/2009

Reston, VASNM and the International Partnership for Critical Markers of Disease (CMOD) are co-hosting an in-depth meeting on Friday, May 1, 2009, examining FDA requirements for manufacturing positron emission tomography (PET) radiopharmaceuticals. The meeting, which takes place at the Natcher Auditorium, National Institutes of Health, Bethesda, Md., is scheduled to begin at 6:10 p.m. and conclude at 9:45 p.m.

"We are pleased to collaborate with the International Partnership for Critical Markers of Disease on this important meeting," said Michael Graham, M.D., Ph.D., SNM president-elect and director of nuclear medicine at the University of Iowa Carver College of Medicine. "New developments in molecular imaging technologies are dramatically improving the ways in which cardiovascular disease, neurological disorders and cancer are diagnosed and treated. It is essential that we work together as a scientific community to facilitate personalized medicine through the development of advanced imaging techniques and new radiopharmaceuticals that will enable physicians to determine early on the precise location of disease, and evaluate and monitor the effectiveness of therapy."

"SNM and CMOD share a common interest in accelerating scientific research to bring the best in health care to patients today," said Thrse Heinonen, DVM, executive director of the International Partnership for Critical Markers of Disease. "With an active interest in the evaluation of potential cardiovascular biomarkers and their appropriate application in clinical trials, a partnership with SNM is a natural fit."

Don Black, head of research and development at GE Healthcare's Medical Diagnostics, Dwaine Rieves, director of medical imaging at the U.S. Food and Drug Administration, and Michael Graham from SNM will kick off the special May 1 evening session. Dennis Swanson, University of Pittsburgh, and Sally Schwarz, Washington University, will survey the regulation history of PET and review current regulations for PET compounding. Joseph Hung, Mayo Clinic, along with other distinguished speakers, will address the critical necessity of developing new tracers and radiopharmaceuticals in compliance with FDA's current good manufacturing practice (CGMP) and chemistry, manufacturing and control (CMC) regulations. Experts will then address the need for harmonization and standardization across multiple imaging sites and discuss the concept of a centralized IND and SNM's new Clinical Trials Network. The meeting will conclude with an interactive question and answer session and panel discussion.

This meeting will take place immediately following SNM's Multimodality Cardiovascular Molecular Imaging Symposium (CVMI), Apr. 30May 1, also at the Natcher Auditorium of the National Institutes of Health. CVMI Symposium attendees may register for this session at no additional charge. For more information about this symposium and to register, please visit www.snm.org/cvmi2009.

SNM and CMOD plan to host other collaborative symposia and forums dedicated to accelerating biomarker and radiopharmaceutical development for patient care, including the 7th annual CMOD Biomarkers and Surrogate Endpoints Symposium, Oct. 19󈞁, 2009, Bethesda, Md. This symposiumwith the theme, "Streamlining to Promote Innovation and Efficiency"will also be held in collaboration with representatives from the FDA, National Institutes of Health, Centers for Disease Control and Prevention, U.S. Agency for Healthcare Research and Quality, Canadian Institutes for Health Research, Radiological Society of North America, and other public and private research organizations. To register for the fall symposium, please visit www.cmod.org.

Registration is free for members of the press or freelancers with a letter of assignment. Press should contact Amy Shaw at ashaw@snm.org or Kathryn Wiley at kwiley@snm.org for more information, or telephone (703) 652-6773.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
2. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
3. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
4. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
5. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
6. SCAI and ACC announce new interventional cardiology meeting
7. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
8. International Society of Hair Restoration Surgery Hosts 15th Annual Scientific Meeting in Las Vegas, September 26-30, 2007
9. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
10. Meeting Expectations Named to First Annual CMI 25 List by Corporate Meetings & Incentives Magazine
11. UNCOVERING THE TRUTH - A Town Hall Meeting on Mental Health Parity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... -- Research and Markets has announced ... Applications, Technologies, Forecasts" report to their offering. ... Smart Skin, Structural Health Monitoring, Composite Smart Structures, ... involves electronic and/or electrical components and circuits that ... such as vehicle bodies or conformally placed upon ...
Breaking Medicine Technology: